ID   VRK3_HUMAN              Reviewed;         474 AA.
AC   Q8IV63; A8KA53; Q502Y2; Q9P2V8;
DT   10-OCT-2003, integrated into UniProtKB/Swiss-Prot.
DT   10-OCT-2003, sequence version 2.
DT   05-OCT-2010, entry version 78.
DE   RecName: Full=Serine/threonine-protein kinase VRK3;
DE            EC=2.7.11.1;
DE   AltName: Full=Vaccinia-related kinase 3;
GN   Name=VRK3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RA   Nezu J.;
RT   "Vaccinia related kinase 3 (VRK3).";
RL   Submitted (AUG-1999) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Ni X., Xie Y., Mao Y.;
RT   "Cloning and characterization of a novel human VRK3 gene.";
RL   Submitted (MAY-2002) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-136, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18187866; DOI=10.2116/analsci.24.161;
RA   Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.;
RT   "Automated phosphoproteome analysis for cultured cancer cells by two-
RT   dimensional nanoLC-MS using a calcined titania/C18 biphasic column.";
RL   Anal. Sci. 24:161-166(2008).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-55 AND SER-59, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-59, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-59; SER-82; SER-83 AND
RP   SER-90, AND MASS SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [9]
RP   VARIANTS [LARGE SCALE ANALYSIS] PHE-59; THR-105; LEU-171; LEU-268;
RP   TYR-288; CYS-370 AND GLY-371.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Probable serine/threonine kinase (By similarity).
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- INTERACTION:
CC       P62826:RAN; NbExp=1; IntAct=EBI-1058605, EBI-286642;
CC       Q6IBS0:TWF2; NbExp=1; IntAct=EBI-1058605, EBI-722204;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8IV63-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8IV63-2; Sequence=VSP_008544, VSP_008545;
CC         Note=No experimental confirmation available;
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CK1 Ser/Thr
CC       protein kinase family. VRK subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB031052; BAA90769.1; -; mRNA.
DR   EMBL; AF514788; AAP47180.1; -; mRNA.
DR   EMBL; AK292918; BAF85607.1; -; mRNA.
DR   EMBL; BC023556; AAH23556.1; -; mRNA.
DR   EMBL; BC095449; AAH95449.1; -; mRNA.
DR   IPI; IPI00009291; -.
DR   IPI; IPI00375335; -.
DR   RefSeq; NP_057524.3; -.
DR   UniGene; Hs.443330; -.
DR   PDB; 2JII; X-ray; 2.00 A; A/B=146-474.
DR   PDBsum; 2JII; -.
DR   ProteinModelPortal; Q8IV63; -.
DR   IntAct; Q8IV63; 5.
DR   STRING; Q8IV63; -.
DR   PhosphoSite; Q8IV63; -.
DR   PRIDE; Q8IV63; -.
DR   Ensembl; ENST00000316763; ENSP00000324636; ENSG00000105053.
DR   GeneID; 51231; -.
DR   UCSC; uc002prg.2; human.
DR   UCSC; uc002prk.1; human.
DR   CTD; 51231; -.
DR   GeneCards; GC19M050479; -.
DR   H-InvDB; HIX0015353; -.
DR   HGNC; HGNC:18996; VRK3.
DR   HPA; HPA016040; -.
DR   PharmGKB; PA134923990; -.
DR   eggNOG; prNOG19396; -.
DR   HOGENOM; HBG715700; -.
DR   HOVERGEN; HBG047756; -.
DR   InParanoid; Q8IV63; -.
DR   OMA; YEEKPPY; -.
DR   OrthoDB; EOG9N0714; -.
DR   PhylomeDB; Q8IV63; -.
DR   BRENDA; 2.7.11.1; 247.
DR   NextBio; 54332; -.
DR   ArrayExpress; Q8IV63; -.
DR   Bgee; Q8IV63; -.
DR   CleanEx; HS_VRK3; -.
DR   Genevestigator; Q8IV63; -.
DR   GermOnline; ENSG00000105053; Homo sapiens.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   Pfam; PF00069; Pkinase; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; FALSE_NEG.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; FALSE_NEG.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Complete proteome;
KW   Kinase; Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    474       Serine/threonine-protein kinase VRK3.
FT                                /FTId=PRO_0000086808.
FT   DOMAIN      166    457       Protein kinase.
FT   NP_BIND     245    253       ATP (By similarity).
FT   ACT_SITE    372    372       Proton acceptor (By similarity).
FT   BINDING     275    275       ATP (By similarity).
FT   MOD_RES      55     55       Phosphoserine.
FT   MOD_RES      59     59       Phosphoserine.
FT   MOD_RES      82     82       Phosphoserine.
FT   MOD_RES      83     83       Phosphoserine.
FT   MOD_RES      90     90       Phosphoserine.
FT   MOD_RES     136    136       Phosphoserine.
FT   VAR_SEQ     407    412       FVDKPG -> LPWDSF (in isoform 2).
FT                                /FTId=VSP_008544.
FT   VAR_SEQ     413    474       Missing (in isoform 2).
FT                                /FTId=VSP_008545.
FT   VARIANT      59     59       S -> F (in dbSNP:rs2033262).
FT                                /FTId=VAR_041295.
FT   VARIANT     105    105       P -> T (in dbSNP:rs11547882).
FT                                /FTId=VAR_041296.
FT   VARIANT     170    170       S -> P (in dbSNP:rs11547881).
FT                                /FTId=VAR_051682.
FT   VARIANT     171    171       F -> L (in dbSNP:rs11547883).
FT                                /FTId=VAR_041297.
FT   VARIANT     188    188       T -> A (in dbSNP:rs11879620).
FT                                /FTId=VAR_051683.
FT   VARIANT     268    268       S -> L (in dbSNP:rs10410075).
FT                                /FTId=VAR_041298.
FT   VARIANT     288    288       C -> Y (in dbSNP:rs10409482).
FT                                /FTId=VAR_041299.
FT   VARIANT     304    304       H -> L (in dbSNP:rs35261919).
FT                                /FTId=VAR_051684.
FT   VARIANT     370    370       R -> C (in dbSNP:rs35331034).
FT                                /FTId=VAR_041300.
FT   VARIANT     371    371       S -> G (in dbSNP:rs56407496).
FT                                /FTId=VAR_041301.
FT   CONFLICT    161    161       K -> E (in Ref. 2; AAP47180).
FT   STRAND      157    159
FT   STRAND      165    175
FT   STRAND      178    185
FT   STRAND      200    206
FT   HELIX       211    221
FT   HELIX       224    233
FT   STRAND      246    250
FT   TURN        251    253
FT   STRAND      254    260
FT   HELIX       266    272
FT   HELIX       274    276
FT   HELIX       280    299
FT   STRAND      311    315
FT   STRAND      318    324
FT   HELIX       327    329
FT   HELIX       335    337
FT   TURN        354    356
FT   HELIX       359    362
FT   HELIX       369    385
FT   HELIX       391    393
FT   HELIX       397    409
FT   HELIX       426    436
FT   HELIX       446    459
SQ   SEQUENCE   474 AA;  52881 MW;  86B9B91050A7F0CC CRC64;
     MISFCPDCGK SIQAAFKFCP YCGNSLPVEE HVGSQTFVNP HVSSFQGSKR GLNSSFETSP
     KKVKWSSTVT SPRLSLFSDG DSSESEDTLS SSERSKGSGS RPPTPKSSPQ KTRKSPQVTR
     GSPQKTSCSP QKTRQSPQTL KRSRVTTSLE ALPTGTVLTD KSGRQWKLKS FQTRDNQGIL
     YEAAPTSTLT CDSGPQKQKF SLKLDAKDGR LFNEQNFFQR AAKPLQVNKW KKLYSTPLLA
     IPTCMGFGVH QDKYRFLVLP SLGRSLQSAL DVSPKHVLSE RSVLQVACRL LDALEFLHEN
     EYVHGNVTAE NIFVDPEDQS QVTLAGYGFA FRYCPSGKHV AYVEGSRSPH EGDLEFISMD
     LHKGCGPSRR SDLQSLGYCM LKWLYGFLPW TNCLPNTEDI MKQKQKFVDK PGPFVGPCGH
     WIRPSETLQK YLKVVMALTY EEKPPYAMLR NNLEALLQDL RVSPYDPIGL PMVP
//
